Please read and agree to the terms and conditions of this site.
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@thenextweb.com 7 years ago
Chan Zuckerberg initiative pledges $3B to wipe out disease
@techcrunch.com 7 years ago
Theranos reportedly voids two years of reports from its Edison blood-testing devices